He Xiaoshan, Jiang Yuting, Hou Hongbiao, Wu Wentao
Department of Infectious Diseases, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.
Diabetes Metab Syndr Obes. 2025 Jul 5;18:2203-2212. doi: 10.2147/DMSO.S523027. eCollection 2025.
This study aimed to investigate whether pretreatment hematological parameters and clinical features are associated with diabetes mellitus (DM) in patients with pulmonary tuberculosis (PTB).
A retrospective study was conducted at Meizhou People's Hospital from April 2016 to December 2020, including 1106 PTB patients-326 PTB-DM patients as the case group and 780 non-DM PTB patients as the control group. The clinical manifestations were collected, and the level of the inflammation index was measured. Receiver operating characteristic (ROC) curves were used to assess the diagnosis and analysis of the selected indices.
There were no significant differences in the clinical manifestations including gender and age distribution, fever, shortness of breath/difficulty in breathing, expectoration, and extrapulmonary tuberculosis (all >0.05). The level of ESR was higher, while the levels of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), system immune inflammation index (SII), and system inflammation response index (SIRI) were lower in PTB-DM patients than those in non-DM PTB patients (all <0.05). Regression analysis showed that erythrocyte sedimentation rate (ESR) (<0.001), MLR (=0.021), and PLR (=0.003) were found as the independent risk factors for DM in PTB patients. The area under ROC curve (AUC) value of ESR was 0.619 (95% CI: 0.590-0.648, cut-off value: 45.5), MLR was 0.600 (95% CI 0.570-0.629, cut-off value: 0.765), PLR was 0.584 (95% CI: 0.554-0.613, cut-off value: 239.615), ESR+MLR was 0.689 (95% CI: 0.661-0.716), ESR+PLR was 0.694 (95% CI: 0.666-0.721), MLR+PLR was 0.610 (95% CI: 0.574-0.645), and ESR+MLR+PLR was 0.712 (95% CI 0.685-0.739), respectively.
ESR, MLR, and PLR are associated with the risk of DM in patients with PTB. In particular, the combined detection of ESR, MLR, and PLR showed higher sensitivity and specificity for the diagnosis of DM among patients with PTB.
本研究旨在探讨肺结核(PTB)患者治疗前的血液学参数和临床特征是否与糖尿病(DM)相关。
2016年4月至2020年12月在梅州市人民医院进行一项回顾性研究,纳入1106例PTB患者,其中326例PTB-DM患者作为病例组,780例非DM的PTB患者作为对照组。收集临床表现,并检测炎症指标水平。采用受试者工作特征(ROC)曲线对所选指标进行诊断和分析。
在性别、年龄分布、发热、呼吸急促/呼吸困难、咳痰和肺外结核等临床表现方面,两组间均无显著差异(均>0.05)。PTB-DM患者的血沉(ESR)水平较高,而中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、单核细胞与淋巴细胞比值(MLR)、全身免疫炎症指数(SII)和全身炎症反应指数(SIRI)均低于非DM的PTB患者(均<0.05)。回归分析显示,红细胞沉降率(ESR)(<0.001)、MLR(=0.021)和PLR(=0.003)是PTB患者发生DM的独立危险因素。ESR的ROC曲线下面积(AUC)值为0.619(95%CI:0.590-0.648,临界值:45.5),MLR为0.600(95%CI 0.570-0.629,临界值:0.765),PLR为0.584(95%CI:0.554-0.613,临界值:239.615),ESR+MLR为0.689(95%CI:0.661-0.716),ESR+PLR为0.694(95%CI:0.666-0.721),MLR+PLR为0.610(95%CI:0.574-0.645),ESR+MLR+PLR为0.712(95%CI 0.685-0.739)。
ESR、MLR和PLR与PTB患者发生DM的风险相关。特别是,联合检测ESR、MLR和PLR对PTB患者DM的诊断具有更高的敏感性和特异性。